Brazil Covaxin Controversy
- All
- News
- Videos
-
Brazil Scraps Covaxin Emergency Use Application Amid Political Row: Report
After suspending the proposed clinical trials of Bharat Bioetch's Covaxin, Brazil has now scrapped the Emergency Use Authorisation request made by the Indian firm for the vaccine.
-
Bharat Biotech Ends Brazil Agreement With 2 Firms Amid Political Row
Drugmaker Bharat Biotech on Friday said it has scrapped agreements with two Brazilian companies amid controversy over a $324 million deal between the South American country and Bharat Biotech for the import of 20 million doses of Covaxin.
-
Brazil Contradicts Bharat Biotech Claim On Emergency Approval For Covaxin
Controversy over a $324 million deal between Brazil and Bharat Biotech - for the import of 20 million Covaxin doses - continues to grow, with reports from the South American country saying its national health regulator never gave the vaccine an EUA.
-
Congress Questions Centre's Silence On Covaxin Pricing Controversy In Brazil
The Congress Party on Friday cornered the central government over the Covaxin pricing controversy in Brazil and asked the Centre why it is "conspicuously silent" on the matter.
-
Bharat Biotech Says 'No Wrongdoing' Amid Row Over Brazil Covaxin Deal
Bharat Biotech has denied any wrongdoing amid a huge controversy in Brazil over a $324 million contract for Covaxin, now suspended over allegations of irregularities that have singed the country's top leadership including President Jair Bolsanaro.
-
Brazil Scraps Covaxin Emergency Use Application Amid Political Row: Report
After suspending the proposed clinical trials of Bharat Bioetch's Covaxin, Brazil has now scrapped the Emergency Use Authorisation request made by the Indian firm for the vaccine.
-
Bharat Biotech Ends Brazil Agreement With 2 Firms Amid Political Row
Drugmaker Bharat Biotech on Friday said it has scrapped agreements with two Brazilian companies amid controversy over a $324 million deal between the South American country and Bharat Biotech for the import of 20 million doses of Covaxin.
-
Brazil Contradicts Bharat Biotech Claim On Emergency Approval For Covaxin
Controversy over a $324 million deal between Brazil and Bharat Biotech - for the import of 20 million Covaxin doses - continues to grow, with reports from the South American country saying its national health regulator never gave the vaccine an EUA.
-
Congress Questions Centre's Silence On Covaxin Pricing Controversy In Brazil
The Congress Party on Friday cornered the central government over the Covaxin pricing controversy in Brazil and asked the Centre why it is "conspicuously silent" on the matter.
-
Bharat Biotech Says 'No Wrongdoing' Amid Row Over Brazil Covaxin Deal
Bharat Biotech has denied any wrongdoing amid a huge controversy in Brazil over a $324 million contract for Covaxin, now suspended over allegations of irregularities that have singed the country's top leadership including President Jair Bolsanaro.
